Study
The longevity gene APOE2 enhances pericyte function and reduces lipid droplets
Human iPSC and mouse models indicate that APOE2 supports brain pericyte function through lipid processing, offering a vascular mechanism for its association with protection from neurodegeneration.
Rais Reskiawan A Kadir and colleagues compared APOE2, APOE3, and APOE4 in humanized knock-in mice and in isogenic human induced-pluripotent-stem-cell-derived pericytes. They also built a human blood–brain barrier model containing endothelial cells, astrocytes, and genotype-specific pericytes. APOE2 expression improved pericyte functional features and reduced lipid-droplet accumulation relative to risk-associated alleles. Proteomic and lipidomic analyses pointed to increased lipid processing as the main cellular difference. Recombinant APOE2 treatment was used to test whether the effect could be transferred to APOE3 and APOE4 pericytes. The result supplies a mechanism that may connect the APOE2 longevity-associated allele with cerebrovascular resilience and lower neurodegenerative risk. It is not a human intervention study. The page does not report a participant sample size, clinical outcomes, or a validated treatment dose. iPSC-derived pericytes and engineered mice model selected biology and may not reproduce aging human vessels. APOE biology is pleiotropic, so enhancing one pathway could have effects in other tissues. The paper supports further work on pericyte lipid metabolism and blood–brain barrier maintenance. It does not justify APOE2 gene therapy, supplements, or self-directed lipid manipulation. Human longitudinal and translational studies are needed before this mechanism can inform prevention.
Preclinical and engineered-cell work. No human intervention, clinical endpoint, or therapeutic dose was tested. The paper reports competing commercial interests for some authors and institutions.